GENE ONLINE|News &
Opinion
Blog

2025-08-27|

LB Pharmaceuticals Files for $100 Million IPO to Fund Schizophrenia Drug Trial

by Bernice Lottering
Share To
LB-102 showed improvement in schizophrenia symptoms in a 359-patient trial, supporting a pivotal Phase 3 launch. Image: iStock
LB Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) to raise up to $100 million in an initial public offering. The company, …

LB Pharmaceuticals Files for $100 Million IPO to Fund Schizophrenia Drug Trial Read More »

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Pittsburgh Steelers Select Priority Technology Holdings to Manage Ticketing Payments and Treasury Operations
2026-07-14
Suja Organic Partners With Ashley Iaconetti for Summer of Loves Campaign
2026-07-14
Tempus Realty Partners Acquires $42 Million in Arkansas Commercial Real Estate
2026-07-14
Tempo Launches Cook Never Club to Reduce Meal Preparation Time for Millennials and Gen Z
2026-07-14
Danielle Fishel and Lance Bass Named QVC Co-Chief Cheer Officers for Christmas in July Event
2026-07-14
Plato’s Closet Launches In-Store Style Simulator for Back-to-School Campaign
2026-07-14
Cheer Holding Launches Klon AI Platform for Digital Portrait Generation
2026-07-14
READ MORE
EVENT
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
SEE MORE
Scroll to Top